Analyst consensus rating
Nuvation Bio Analyst Rating: Strong Buy
Direct answer
Nuvation Bio's consensus rating is Strong Buy.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $13.00.
Forecast evidence checked October 14, 2026.
Get free Nuvation Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.72
- Average price target
- $13.00
- High price target
- $21.00
- Low price target
- $7.00
- Low target gap
- +48.3%
- Target upside
- +175.4%
- High target gap
- +344.9%
- Target range width
- 296.6%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- October 14, 2026
- Valid through
- October 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Nuvation Bio?
Nuvation Bio has a verified Strong Buy consensus. The same dataset has an average price target of $13.00.
How far are Nuvation Bio's low and high targets from the recorded price?
The low target implies +48.3%, while the high target implies +344.9%.
How many analysts are included in Nuvation Bio's consensus?
The verified consensus includes 11 analysts.
How is Nuvation Bio's target upside or downside calculated?
The average target of $13.00 is divided by the recorded price of $4.72, then one is subtracted to produce +175.4%. This does not guarantee a future return.
When was Nuvation Bio's analyst forecast verified?
The data was verified on 2026-10-14. The dataset is valid through 2026-10-21.